Dr Stock Pick HOT News & Alerts!

FREE Daily Stock Alerts From DrStockPick.com

DrStockPick.com Stock Watch!
My Pick For Friday April 23, 2010 is:
*******************
PWRM, Power 3 Medical Products Inc., PWRM.OB
More on PWRM:
Just take a look at the size of the potential market (people who would benefit) from PWRM’s diagnostic tests and drug targets:
- According to recent estimates, as many as 2.4 million to 4.5 million Americans have Alzheimer’s disease (AD). Unless the disease can be effectively treated or prevented, the number of people with AD will increase significantly if current population trends continue. That’s because the risk of AD increases with age, and the U.S. population is aging. The number of people age 65 and older is expected to grow from 39 million in 2008 to 72 million in 2030, and the number of people with AD doubles for every 5-year interval beyond age 65. (Source: CLICK HERE)
Early and careful evaluation is important because many conditions can cause dementia, some of which are treatable or reversible. Potentially reversible conditions include depression, adverse drug reactions, metabolic changes, and nutritional deficiencies. The earlier an accurate diagnosis of Alzheimer’s disease is made, the greater the gain in managing symptoms and allowing the person to take part in planning for their future.
- A person with ALS (Lou Gehrig’s disease) can develop symptoms ranging from problems in dexterity or gait resulting from muscle weakness to difficulty speaking or swallowing. Sphincter control, sensory function, intellectual ability, and skin integrity are preserved. Patients become paralyzed and often require ventilation and surgery to provide a new opening in the stomach (gastrostomy). Loss of respiratory function is ultimately the cause of death. As many as 20,000 Americans have ALS, and an estimated 5,000 people in the United States are diagnosed with the disease each year. ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds are affected. ALS most commonly strikes people between 40 and 60 years of age, but younger and older people can also develop the disease. Men are affected more often than women. (Source: CLICK HERE)
- Parkinson’s disease is a progressive disorder of the central nervous system that affects more than 1.5 million people in the United States. The main features of Parkinson’s disease are slowness of movements, compromise of balance, muscle rigidity, and tremors. The disease is thought to be caused by low levels of a chemical called dopamine, which activates cells in our brains that let us move.
- The American Cancer Society’s most recent estimates for breast cancer in the United States are for 2009: 192,370 new cases of invasive breast cancer and 40,170 deaths from breast cancer
Breast cancer is the most common cancer among women in the United States, other than skin cancer. It is the second leading cause of cancer death in women, after lung cancer. The chance of a woman having invasive breast cancer some time during her life is a little less than 1 in 8. The chance of dying from breast cancer is about 1 in 35.
But check this out:
Breast cancer death rates have been going down. This is probably the result of finding the cancer earlier and providing better treatment. Right now there are more than 2½ million breast cancer survivors in the United States. (SOURCE: CLICK HERE)
As you’ve just read, products with the potential of PWRM’s patent-pending technologies are required immediately for the humanity!
Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.
PWRM’s products could save millions of lives worldwide!!
PWRM expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer’s disease (NuroPro-AD), Parkinson’s disease (NuroPro-PD) and breast cancer in 2010, followed by filings with the FDA.
There is still time to include PWRM to your watch list!
Companies with these kind of technologies could find their trading levels change in a positive direction in no time!
So keep a close eye on PWRM from now on!!
More about PWRM at www.Power3Medical.com
**************************************************************
***********Advertisement***********















********************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com End Of day publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick Stock Watch report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) . Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and it has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB).